C. Meijer et al., IMMUNOCYTOCHEMICAL ANALYSIS OF CISPLATIN-INDUCED PLATINUM-DNA ADDUCTSWITH DOUBLE-FLUORESCENCE VIDEO MICROSCOPY, British Journal of Cancer, 76(3), 1997, pp. 290-298
To detect low-level DNA platination, a sensitive immunocyto- and histo
chemical technique was developed using a polyclonal antibody. The anti
body GPt, derived after immunization of rabbits with highly platinated
DNA and purified with affinity chromatography, detected the main plat
inum (Pt)-containing intrastrand and interstrand adducts. Double-fluor
escence microscopy image analysis was used to quantify Pt-DNA adducts
with Hoechst 33258 fluorescence to locate the nuclei and with fluoresc
ein isothiocyanate fluorescence to measure the immunosignal. A two- to
five-fold dose-dependent difference in the level of cisplatin (CDDP)-
induced Pt-DNA adducts between a CDDP-sensitive and -resistant human t
umour cell line was detected. Large differences in Pt-DNA adduct level
s after in vitro CDDP incubation between human buccal cells, lymphocyt
es and biopsies of different tumour types were observed. Pt-DNA adduct
levels were fivefold higher in human testicular tumours than in colon
tumours, representing CDDP-sensitive and -resistant tumours, respecti
vely, in the clinic. These data suggest the possibility of predictive
testing by measuring Pt-DNA adduct levels. Pt-DNA adducts in patients
after treatment with CDDP were shown in normal buccal cells and in imp
rints of fresh tumour biopsies as well as in paraffin-embedded tumour
cells. The analysis of Pt-DNA adducts at a single-cell level in small
samples of normal and tumour cells during and/or after treatment is fe
asible with GPt and will hopefully enable more selective treatment of
patients.